Manmei Long

701 total citations
22 papers, 465 citations indexed

About

Manmei Long is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Manmei Long has authored 22 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Manmei Long's work include MicroRNA in disease regulation (6 papers), Sarcoma Diagnosis and Treatment (5 papers) and Neurofibromatosis and Schwannoma Cases (5 papers). Manmei Long is often cited by papers focused on MicroRNA in disease regulation (6 papers), Sarcoma Diagnosis and Treatment (5 papers) and Neurofibromatosis and Schwannoma Cases (5 papers). Manmei Long collaborates with scholars based in China and France. Manmei Long's co-authors include Ming Zhan, Sunwang Xu, Jian Wang, Yongheng Shi, Man Mohan, Ruimeng Yang, Wei Chen, Qiang Liu, Wei Chen and Yiwei Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and PLoS ONE.

In The Last Decade

Manmei Long

21 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manmei Long China 9 336 281 98 76 58 22 465
Yuqing Ma China 11 324 1.0× 264 0.9× 87 0.9× 65 0.9× 96 1.7× 25 456
Fengying Du China 9 338 1.0× 220 0.8× 120 1.2× 127 1.7× 52 0.9× 24 490
Zetian Shen China 13 214 0.6× 174 0.6× 109 1.1× 126 1.7× 70 1.2× 30 439
Fengyan Han China 12 363 1.1× 246 0.9× 65 0.7× 78 1.0× 28 0.5× 24 536
Hiroyuki Yasuda Japan 10 446 1.3× 183 0.7× 117 1.2× 155 2.0× 23 0.4× 16 557
Ju Guo China 13 286 0.9× 190 0.7× 74 0.8× 161 2.1× 67 1.2× 41 458
Pierre Frères Belgium 10 310 0.9× 259 0.9× 71 0.7× 34 0.4× 28 0.5× 24 445
Juanyi Shi China 13 503 1.5× 444 1.6× 68 0.7× 111 1.5× 56 1.0× 29 626
Wenzheng Yuan China 8 304 0.9× 176 0.6× 179 1.8× 64 0.8× 21 0.4× 8 458
Renba Liang China 10 212 0.6× 150 0.5× 145 1.5× 53 0.7× 36 0.6× 14 400

Countries citing papers authored by Manmei Long

Since Specialization
Citations

This map shows the geographic impact of Manmei Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manmei Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manmei Long more than expected).

Fields of papers citing papers by Manmei Long

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manmei Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manmei Long. The network helps show where Manmei Long may publish in the future.

Co-authorship network of co-authors of Manmei Long

This figure shows the co-authorship network connecting the top 25 collaborators of Manmei Long. A scholar is included among the top collaborators of Manmei Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manmei Long. Manmei Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Long, Manmei, et al.. (2024). STING is significantly increased in high-grade glioma with high risk of recurrence. OncoImmunology. 13(1). 2327682–2327682. 3 indexed citations
2.
Zhang, Kaiwen, Manmei Long, Yu Liu, et al.. (2023). ALYREF-mediated RNA 5-Methylcytosine modification Promotes Hepatocellular Carcinoma Progression Via Stabilizing EGFR mRNA and pSTAT3 activation. International Journal of Biological Sciences. 20(1). 331–346. 28 indexed citations
3.
Yang, Ruifeng, Linhua Yang, Manmei Long, et al.. (2023). Taurodeoxycholic acid-YAP1 upregulates OTX1 in promoting gallbladder cancer malignancy through IFITM3-dependent AKT activation. Oncogene. 42(18). 1466–1477. 8 indexed citations
4.
Gao, Duo, et al.. (2023). Oral Delivery of Gemcitabine-Loaded Glycocholic Acid-Modified Micelles for Cancer Therapy. ACS Nano. 17(18). 18074–18088. 14 indexed citations
5.
Gu, Yihui, Chengjiang Wei, Haibo Li, et al.. (2023). FOXM1 promotes neurofibromatosis type 1-associated malignant peripheral nerve sheath tumor progression in a NUF2-dependent manner. Cancer Gene Therapy. 30(10). 1390–1402. 4 indexed citations
6.
Li, Haibo, Yuehua Li, Chengjiang Wei, et al.. (2023). RRM2 as a novel prognostic and therapeutic target of NF1-associated MPNST. Cellular Oncology. 46(5). 1399–1413. 6 indexed citations
7.
Gu, Yihui, Yuehua Li, Haibo Li, et al.. (2022). Preclinical Assessment of MEK Inhibitors for Malignant Peripheral Nerve Sheath Tumors Reveals Differences in Efficacy and Adaptive Response. Frontiers in Oncology. 12. 903177–903177. 6 indexed citations
8.
Gu, Yihui, Chengjiang Wei, Haibo Li, et al.. (2022). Concurrent inhibition of FAK/SRC and MEK overcomes MEK inhibitor resistance in Neurofibromatosis Type I related malignant peripheral nerve sheath tumors. Frontiers in Oncology. 12. 910505–910505. 7 indexed citations
9.
Wang, Wei, Manmei Long, Chengjiang Wei, et al.. (2021). Clinical comparison of tenosynovial giant cell tumors, synovial chondromatosis, and synovial sarcoma: analysis and report of 53 cases. Annals of Translational Medicine. 9(13). 1059–1059. 2 indexed citations
10.
Shen, Yanting, Huan Xu, Manmei Long, et al.. (2021). Screening to Identify an Immune Landscape-Based Prognostic Predictor and Therapeutic Target for Prostate Cancer. Frontiers in Oncology. 11. 761643–761643. 2 indexed citations
11.
Gu, Yihui, Manmei Long, Chengjiang Wei, et al.. (2021). Selection of internal references for RT-qPCR assays in Neurofibromatosis type 1 (NF1) related Schwann cell lines. PLoS ONE. 16(2). e0241821–e0241821. 6 indexed citations
12.
Long, Manmei, et al.. (2021). Two Ectopic Hamartomatous Thymomas of Suprasternal Region of the Neck in A Single Patient: A Case Report. SHILAP Revista de lepidopterología. 3(1). 51–55. 1 indexed citations
13.
Gu, Yihui, Manmei Long, Chengjiang Wei, et al.. (2020). Protein Tyrosine Phosphatase Receptor S Acts as a Metastatic Suppressor in Malignant Peripheral Nerve Sheath Tumor via Profilin 1-Induced Epithelial-Mesenchymal Transition. Frontiers in Cell and Developmental Biology. 8. 582220–582220. 6 indexed citations
14.
Cao, Rong, Keqi Wang, Manmei Long, et al.. (2020). miR-3613-5p enhances the metastasis of pancreatic cancer by targeting CDK6. Cell Cycle. 19(22). 3086–3095. 15 indexed citations
15.
Song, Shangqing, Manmei Long, Guopeng Yu, et al.. (2019). Urinary exosome miR‐30c‐5p as a biomarker of clear cell renal cell carcinoma that inhibits progression by targeting HSPA5. Journal of Cellular and Molecular Medicine. 23(10). 6755–6765. 88 indexed citations
16.
Long, Manmei, et al.. (2018). Epithelioid angiosarcoma of the liver: report of two cases and review of the literature.. PubMed. 11(6). 3191–3198. 2 indexed citations
17.
Long, Manmei, Ming Zhan, Sunwang Xu, et al.. (2017). miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer. Molecular Cancer. 16(1). 167–167. 90 indexed citations
18.
Yang, Ruimeng, Ming Zhan, Sunwang Xu, et al.. (2017). miR-3656 expression enhances the chemosensitivity of pancreatic cancer to gemcitabine through modulation of the RHOF/EMT axis. Cell Death and Disease. 8(10). e3129–e3129. 39 indexed citations
19.
Wang, Hui, Ming Zhan, Sunwang Xu, et al.. (2017). miR-218-5p restores sensitivity to gemcitabine through PRKCE/MDR1 axis in gallbladder cancer. Cell Death and Disease. 8(5). e2770–e2770. 58 indexed citations
20.
He, Min, Ming Zhan, Wei Chen, et al.. (2017). MiR-143-5p Deficiency Triggers EMT and Metastasis by Targeting HIF-1α in Gallbladder Cancer. Cellular Physiology and Biochemistry. 42(5). 2078–2092. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuqing Ma Breakdown of academic impact, for papers by Fengying Du Breakdown of academic impact, for papers by Zetian Shen Breakdown of academic impact, for papers by Fengyan Han Breakdown of academic impact, for papers by Hiroyuki Yasuda Breakdown of academic impact, for papers by Ju Guo Breakdown of academic impact, for papers by Pierre Frères Breakdown of academic impact, for papers by Juanyi Shi Breakdown of academic impact, for papers by Wenzheng Yuan Breakdown of academic impact, for papers by Renba Liang
Rankless by CCL
2026